A novel association of osmotic demyelination in Sjögren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review
Tài liệu tham khảo
Adams, 1959, Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients, AMA Arch Neurol Psychiatry, 81, 154, 10.1001/archneurpsyc.1959.02340140020004
Martin, 2004, Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes, J Neurol Neurosurg Psychiatry, 75, iii22, 10.1136/jnnp.2004.045906
Lambeck, 2019, Central Pontine Myelinosis and Osmotic Demyelination Syndrome, Dtsch Ärztebl Int, 116, 600
Lohr, 1994, Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia, Am J Med, 96, 408, 10.1016/0002-9343(94)90166-X
Fox, 2005, Sjögren's syndrome, Lancet, 366, 321, 10.1016/S0140-6736(05)66990-5
Delalande, 2004, Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients, Medicine (Baltimore), 83, 280, 10.1097/01.md.0000141099.53742.16
Sandhya, 2014, Sjögren's, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series, Open Rheumatol J, 8, 103, 10.2174/1874312901408010103
Ramos-Casals, 2015, Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements, Rheumatology, 54, 2230, 10.1093/rheumatology/kev200
Sandhya, 2022, Comprehensive analysis of clinical and laboratory features of 440 published cases of Sjögren's syndrome and renal tubular acidosis, Int J Rheum Dis
Akaishi, 2020, Risk factors of attacks in neuromyelitis optica spectrum disorders, J Neuroimmunol, 343, 10.1016/j.jneuroim.2020.577236
Cruz, 2021, Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist, Curr Rheumatol Rep, 23, 33, 10.1007/s11926-021-01000-2
Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729
Nagashima, 1996, A patient with Sjögren syndrome with central pontine myelinolysis and hypokalemic myopathy, Rinsho Shinkeigaku, 36, 1240
Yoon, 2000, Central pontine myelinolysis–a rare manifestation of CNS Sjogren's syndrome, Lupus, 9, 471, 10.1191/096120300678828550
Berlot, 2008, Hyperammoniemia and central pontine myelinolysis in a patient with Sjögren syndrome and chronic valproate use, Recenti Prog Med, 99, 502
Watson, 2009, A Case of Sjogren's Syndrome with Renal Tubular Acidosis and Central Pontine Myelinolysis Concurrent Oral 9 – Case Reports [OP55–OP62], Rheumatology, 48, i20
Naziha, 2010, [Central pontine myelinolysis in Sjogren's syndrome], Tunis Med, 88, 215
Cheah, 2012, A combination of extraglandular manifestations of Sjögren's syndrome, Int J Rheum Dis, 15, e156, 10.1111/j.1756-185X.2011.01636.x
Rubo, 2013, Primary Sjogren's Syndrome Presenting with Renal Tubular Acidosis and Central Pontine Myelinolysis: A Case Report, Arch Rheumatol, 28, 058
Chang, 2014, Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy, BMC Nephrol, 15, 56, 10.1186/1471-2369-15-56
Saxena, 2016, Primary Sjogren's Syndrome with Renal Tubular Acidosis with Central Pontine Myelinolysis - A rare case report, IAIM, 3, 274
Abdulla, 2017, Central pontine myelinolysis in Sjogren's syndrome with hypokalemia, Int J Rheum Dis, 20, 2168, 10.1111/1756-185X.12847
Mellat, 2016, Central pontine and extrapontine myelinolysis induced by severe hypokalemia, a rare manifestation of Sjögren's syndrome, Journal of Case Reports in Practice, 4, 46
Aksenova, 2018, Central pontine and extrapontine myelinolysis in girl with sjögren's syndrome, Pediatr Nephrol, 33, 1807
Bruns, 2020, Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto's Thyroiditis and Central Pontine Myelinolysis, Front Endocrinol, 11, 10.3389/fendo.2020.548877
Maturu, 2021, Rare Case of Central Pontine Myelinolysis: Etiological Dilemma, Cureus, 13, e19644
Paul, 2022, Quadriplegia, due to hypokalaemia and related osmotic demyelination syndrome, as an initial presentation of Sjogren's syndrome, J Clin Med Surgery, 2, 1039
Taneichi, 1987, Aseptic meningoencephalitis in Sjögren's syndrome, Jpn J Clin Immunol, 10, 207, 10.2177/jsci.10.207
Ragupathi, 2016, Distal Renal Tubular Acidosis and Diabetes Insipidus Leading to the Diagnosis Of Sjögren's Syndrome, Med Forum, 17, 10.29046/TMF.017.1.016
García-Alfonso, 2020, Onset of primary Sjögren syndrome with mitochondrial polymyositis, axonal neuropathy, and hypokalaemic paralysis: Case report, Rev Colomb Reumatol, 27, 158
Muaddi, 2021, Topiramate-induced severe electrolyte abnormalities and hypernatremia leading to central pontine myelinolysis, BMJ Case Rep CP, 14
Hong, 1996, A chronic glue sniffer with hyperchloraemia metabolic acidosis, rhabdomyolysis, irreversible quadriplegia, central pontine myelinolysis, and hypothyroidism, Nephrol Dial Transplant, 11, 1848, 10.1093/oxfordjournals.ndt.a027683
Hoshino, 2008, Pontine hemorrhage in a patient with type 1 renal tubular acidosis associated with osmotic demyelination syndrome, Brain Nerve Shinkei Kenkyu No Shinpo, 60, 1061
Imbe, 2010, Neuromyelitis optica in a patient with Sjögren syndrome with distal renal tubular acidosis: case report, Rinsho Shinkeigaku, 50, 168, 10.5692/clinicalneurol.50.168
Rajagopala, 2015, An unusually dry story, Indian J Crit Care Med, 19, 550, 10.4103/0972-5229.164808
Martín-Nares, 2019, Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience, Lupus, 28, 1302, 10.1177/0961203319877255
Ismail, 2013, Clinical Semiology and Neuroradiologic Correlates of Acute Hypernatremic Osmotic Challenge in Adults: A Literature Review, Am J Neuroradiol, 34, 2225, 10.3174/ajnr.A3392
Garofeanu, 2005, Causes of reversible nephrogenic diabetes insipidus: a systematic review, Am J Kidney, 45, 626, 10.1053/j.ajkd.2005.01.008
Davenport, 2010, Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus, Ann Clin Biochem, 47, 86, 10.1258/acb.2009.009094
Heng, 2007, Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia, Clin Nephrol, 67, 345, 10.5414/CNP67345
Kallakatta, 2011, Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients, J Neurol Neurosurg Psychiatry, 82, 326, 10.1136/jnnp.2009.201764
Azad, 2021, Human Aquaporins: Functional Diversity and Potential Roles in Infectious and Non-infectious Diseases, Front Genet, 12, 10.3389/fgene.2021.654865
Delporte, 2016, Aquaporins in Salivary Glands: From Basic Research to Clinical Applications, Int J Mol Sci, 17, E166, 10.3390/ijms17020166
Soyfoo, 2018, Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome, Int J Mol Sci, 19, 3392, 10.3390/ijms19113392
Beroukas, 2002, Selective Down-Regulation of Aquaporin-1 in Salivary Glands in Primary Sjögren's Syndrome, Lab Invest, 82, 1547, 10.1097/01.LAB.0000038502.42845.9E
Sisto, 2017, Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients, Autoimmunity, 50, 202, 10.1080/08916934.2017.1341495
Steinfeld, 2001, Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients, Lab Investig J Tech Methods Pathol, 81, 143, 10.1038/labinvest.3780221
Soyfoo, 2007, Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy, Arthritis Rheum, 56, 2566, 10.1002/art.22826
Yoshimura, 2016, Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients, Mod Rheumatol, 26, 384, 10.3109/14397595.2015.1083146
Yamamura, 2012, TNF-α inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation, J Cell Mol Med, 16, 1766, 10.1111/j.1582-4934.2011.01456.x
Yao, 2010, Potential down-regulation of salivary gland AQP5 by LPS via cross-coupling of NF-kappaB and p-c-Jun/c-Fos, Am J Pathol, 177, 724, 10.2353/ajpath.2010.090282
Lee, 2013, Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 trafficking, PloS One, 8, e53113, 10.1371/journal.pone.0053113
Chivasso, 2021, Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sjögren's Syndrome, Int J Mol Sci, 22, 9213, 10.3390/ijms22179213
Chivasso, 2021, Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients, Cells, 10, 2108, 10.3390/cells10082108
Alam, 2016, Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sjögren's syndrome, Immunol Res, 64, 848, 10.1007/s12026-016-8786-x
Alam, 2017, Detection of Autoantibodies against Aquaporin-1 in the Sera of Patients with Primary Sjögren's Syndrome, Immune Netw, 17, 103, 10.4110/in.2017.17.2.103
Tzartos, 2017, Antibodies to aquaporins are frequent in patients with primary Sjögren's syndrome, Rheumatology, 56, 2114, 10.1093/rheumatology/kex328
Jeon, 2019, Associations of Anti-Aquaporin 5 Autoantibodies with Serologic and Histopathological Features of Sjögren's Syndrome, J Clin Med, 8, 1863, 10.3390/jcm8111863
Su, 2020, Aquaporins in the kidney: physiology and pathophysiology, Am J Physiol Renal Physiol, 318, F193, 10.1152/ajprenal.00304.2019
Khositseth, 2015, Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus, Sci Rep, 5, 1, 10.1038/srep18311
Shchepareva, 2020, Functional Role of Aquaporins in the Nervous System under Normal and Pathological Conditions, Neurochem J, 14, 1, 10.1134/S1819712420010171
Szczygielski, 2021, Cerebral Microcirculation, Perivascular Unit, and Glymphatic System: Role of Aquaporin-4 as the Gatekeeper for Water Homeostasis, Front Neurol, 12, 10.3389/fneur.2021.767470
Nagelhus, 2013, Physiological roles of aquaporin-4 in brain, Physiol Rev, 93, 1543, 10.1152/physrev.00011.2013
Song, 2012, Potassium Dependent Regulation of Astrocyte Water Permeability Is Mediated by cAMP Signaling, PLoS ONE, 7, e34936, 10.1371/journal.pone.0034936
Popescu, 2013, Evidence of aquaporin involvement in human central pontine myelinolysis, Acta Neuropathol Commun, 1, 40, 10.1186/2051-5960-1-40
Yin, 2018, Hypertonic Saline Alleviates Brain Edema After Traumatic Brain Injury via Downregulation of Aquaporin 4 in Rats, Med Sci Monit, 24, 1863, 10.12659/MSM.907212
Zeng, 2010, Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes, Neuroscience, 166, 878, 10.1016/j.neuroscience.2009.12.076
Zekeridou, 2015, Aquaporin-4 autoimmunity, Neurol Neuroimmunol Neuroinflammation, 2, e110, 10.1212/NXI.0000000000000110
Misu, 2007, Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis, Brain J Neurol, 130, 1224, 10.1093/brain/awm047
Hinson, 2009, Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells, Arch Neurol, 66, 1164, 10.1001/archneurol.2009.188
Tradtrantip, 2017, Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica, Acta Neuropathol (Berl), 134, 35, 10.1007/s00401-017-1734-6
Ratelade, 2012, Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies, Int J Biochem Cell Biol, 44, 1519, 10.1016/j.biocel.2012.06.013
Akaishi, 2021, Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder, Neurology, 97, e1, 10.1212/WNL.0000000000012175
Nishiyama, 2009, A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset, Neurology, 72, 1960, 10.1212/WNL.0b013e3181a82621
Lin, 2022, Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders, Mult Scler Relat Disord, 58, 10.1016/j.msard.2022.103494
Park, 2015, Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder, J Neurol Sci, 348, 132, 10.1016/j.jns.2014.11.020
Akaishi, 2021, Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders, J Neurol, 268, 1938, 10.1007/s00415-020-10377-6
Hor, 2020, Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide, Front Neurol, 11, 501, 10.3389/fneur.2020.00501
Sakai, 2014, Case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion, Rinsho Shinkeigaku, 54, 556, 10.5692/clinicalneurol.54.556
Kariv, 2018, Case Report: Osmotic Demyelination Syndrome in an Adolescent with Neuromyelitis Optica, Int J MS Care, 20, 142, 10.7224/1537-2073.2016-077
Ghosh, 2020, Jaw clonus in neuromyelitis optica spectrum disorder with subsequent osmotic demyelination syndrome, J Fam Med Prim Care, 9, 1209, 10.4103/jfmpc.jfmpc_1117_19
Qiao, 2015, The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article, Medicine (Baltimore), 94, e1145, 10.1097/MD.0000000000001145
Seror, 2015, EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide, RMD Open, 1, 10.1136/rmdopen-2014-000022
Birnbaum, 2017, The Relationship Between the Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-occurring Autoimmunity?, Arthritis Care Res, 69, 1069, 10.1002/acr.23107
Tzartos, 2013, Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders, PLOS ONE, 8, e74773, 10.1371/journal.pone.0074773
Shiboski, 2017, 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts, Ann Rheum Dis, 76, 9, 10.1136/annrheumdis-2016-210571